The Infuse Bone Graft has been used in thousands of spinal fusion surgeries used to treat severe back pain. The goal of the product was to help fuse vertebrae in a patient’s lower spine in order to treat degenerative disc disease. It was originally approved by the Food and Drug Administration (FDA) in 2002 under the specific product name “Infuse Bone Graft/LT-CAGE Lumbar Tapered Fusion Device – P000058”. The Infuse Bone Graft is manufactured and sold by Medtronic, a medical device company in the United States. Background on Medtronic’s Bone Graft Medical Device Claims Earning wages is difficult or at times impossible, placing further pressure on an individual’s financial situation. The unfortunate combination of elongated litigation and a loss of wages is often a dangerous one and can result in devastating consequences for plaintiffs. Thankfully, Infuse Bone Graft settlement loans can level the playing field and provide injured victims with immediate monetary support. As if the long wait is not enough, injuries sustained by the Infuse Bone Graft multiply the severity of a plaintiff’s situation during such time.

The duration of litigation is even more elongated when dealing with a multi-million dollar company like Medtronic. Plaintiffs who fall on hard financial times during litigation can seek help by contacting a lawsuit funding company that is willing to accept Infuse Bone Graft cases.ĭefective medical product lawsuits can drag out extensively, making plaintiffs wait years until they receive the payout award they deserve. Also known as lawsuit funding, settlement loans provide plaintiffs the ability to receive a portion of their future settlement payout now instead of later. Infuse Bone Graft settlement loans are available for plaintiffs who were injured by the product and are now pursuing a claim against Medtronic. 'The expanded approval with these PEEK devices for OLIF25, OLIF51 and ALIF procedures provide important options for surgeons and their patients.A+ Rated Since 2015 Settlement Loans for Infuse Bone Graft Lawsuit 'Infuse Bone Graft remains one of the most-extensively studied products in spine that is commercially available today,' Doug King, senior vice president and president, Medtronic's Spine division, said in a statement. This is the second expanded indication in 2 years. More than 1 million patients have used Infuse, as it has been on the market since 2002. Infuse Bone Graft is approved for certain spine, oral-maxillofacial and orthopedic trauma surgeries. The Infuse/Medtronic Interbody Fusion Device consists of 2 components containing 3 parts - a spinal fusion cage, a recombinant human bone morphogenetic protein and a carrier/scaffold for the bone morphogenetic protein and resulting bone. The device is designed for use with certain Medtronic interbody fusion devices to treat lumbar degenerative disc disease. In surgery, it’s applied to an absorbable collagen sponge, which is a carrier to deliver the rhBMP-2 to the implant site, acting as a scaffold for the formation of new bone - it then will resorb or disappear over time. The Infuse implant contains the active ingredient rhBMP-2, a manufactured version of a bone growth protein normally present in the body. “This latest approval addresses some fairly common degenerative spine surgical correction needs.”

“Different spine patients can have very different surgical needs, so the more options surgeons have to combine a clinically-proven bone grafting technology like Infuse with different procedures and implants, the greater the likelihood of successful outcomes,” Richard Hynes, MD, FACS, president and spine surgeon, B.A.C.K Center, said in a statement. The newly approved indications include use in OLIF 51 procedures with Divergence-L®Interbody Fusion Device at a single level from L5-S1 use in OLIF 25 procedures with Pivox Oblique Lateral Spine System at a single level from L2–L5 and use in ALIF procedures with Divergence-LInterbody Fusion Device at a single level from L2–S1. Medtronic announced that the US Food and Drug Administration (FDA) approved Infuse™ Bone Graft in new spine surgery indications with additional spine implants made of polyetheretherketone (PEEK) in oblique lateral interbody fusion (OLIF 25™ and OLIF 51™) and anterior lumbar interbody fusion (ALIF) procedures at a single level.

Infuse bone graft